Picture of Valbiotis SA logo

ALVAL — Valbiotis SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Valbiotis FY Operating Loss Narrows To EUR 3.4 Mln

March 17 (Reuters) - VALBIOTIS SA  ALVAL.PA :
    * FY REVENUE 3.092 MILLION EUR
    * EUR 14.6M IN CASH AS AT DECEMBER 31, 2020
    * IN 2020, VALBIOTIS GENERATED A TURNOVER OF EUR 3,092K
    * FY NET LOSS EUR 3.8 MILLION VERSUS LOSS OF EUR 5.5 MILLION
YEAR
AGO
    * A SERIES OF PRECLINICAL EXPERIMENTS WILL ALSO BE LAUNCHED
AND
COMPLETED IN 2021: STUDIES SHOULD PROVIDE FURTHER DETAILS ON
IMPACT OF TOTUM-070 ON LIPID METABOLISM IN A PREDICTIVE MODEL OF
HUMAN PATHOPHYSIOLOGY
    * FY OPERATING LOSS EUR 3.4 MILLION VERSUS LOSS OF EUR 5.2
MILLION
YEAR AGO

Source text for Eikon:  ID:nBwQqxHFa 
Further company coverage:  ALVAL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Valbiotis SA

See all news